-
- 抗原 See all IL-13 (IL13) 抗体
- IL-13 (IL13) (Interleukin 13 (IL13))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This IL-13 antibody is un-conjugated
-
应用范围
- ELISA, Flow Cytometry (FACS), Functional Studies (Func)
- 特异性
- Recognises both natural and recombinant human IL-13
- 纯化方法
- Ion exchange chromatography
- 过滤
- 0.22 μm filtered
- 免疫原
- Recombinant human IL-13,Myeloma X63/AG.8653 x Balb/c spleen cells
- 克隆位点
- B-B13
- 亚型
- IgG1 kappa
- Biological Activity Comment
- Inhibits IL-13 induced proliferation on TF1 cell line
- Top Product
- Discover our top product IL13 Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
- 储存液
- Without preservative
- 储存条件
- 4 °C
- 储存方法
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig." in: Blood, Vol. 101, Issue 8, pp. 3325-33, (2003) (PubMed).
: "Human eosinophils express and release IL-13 following CD28-dependent activation." in: Journal of leukocyte biology, Vol. 72, Issue 4, pp. 769-79, (2002) (PubMed).
: "Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 156, Issue 5, pp. 1818-23, (1996) (PubMed).
: "
-
Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig." in: Blood, Vol. 101, Issue 8, pp. 3325-33, (2003) (PubMed).
-
- 抗原
- IL-13 (IL13) (Interleukin 13 (IL13))
- 别名
- IL-13 (IL13 产品)
- 途径
- JAK/STAT Signaling, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Proton Transport
-